S. Pok

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

Jun Yu, Xiangchun Li, Lixia Xu, 2018, Nature Communications.

Exercise retards hepatocarcinogenesis in obese mice independently of weight control.

M. Yeh, G. Ioannou, G. Farrell, 2020, Journal of hepatology.

miR‐181a mediates TGF‐β‐induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer

J. Gamble, M. Vadas, G. McCaughan, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

Jun Yu, Xiangchun Li, Lixia Xu, 2018, Nature Communications.

Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis

G. Farrell, A. Alsop, N. Shackel, 2013, Journal of gastroenterology and hepatology.

Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis

A. Blackburn, G. Farrell, N. Teoh, 2016, Journal of gastroenterology and hepatology.

Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer research

G. Farrell, Y. Dan, N. Teoh, 2017, Experimental cell research.

Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.

S. Brenner, B. Venkatesh, A. Ullrich, 2007, Cancer research.

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.

A. Ullrich, M. Aung, S. Lim, 2009, Journal of hepatology.

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.

A. Ullrich, M. Aung, S. Lim, 2009, Journal of hepatology.

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.

A. Ullrich, M. Aung, S. Lim, 2009, Journal of hepatology.